Report Cover

Global Meloxicam Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    by Ingredient
        Combination Drugs
        Prescribed Drugs
    by Route
        Oral
        Intravenou
    by Dosage Form
        Tablets
        Capsule
        Granules
        Other

Segment by Application
    Rheumatoid Arthritis
    Osteoarthritis
    Soft Tissue Inflammation
    Traumatic Pain
    Post-Operative Pain
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Boehringer Ingelheim
    Baudax
    Perrigo
    Recro Pharma
    Iroko Pharma
    Zyla Life Sciences
    Axsome Therapeutics
    Orbis Biosciences
    Cellix Bio
    Ligand Pharma
    SEDOR Pharma
    Heron Therapeutics
    Pacira BioSciences
    Sanofi
    Eurofarma Laboratorio
    TerSera Therapeutics
    Apotex
    Yung Shin Pharmaceutical
    Breckenridge Pharmaceutical
    Zydus Pharmaceuticals
    Unichem Pharmaceuticals
    Strides Pharma
    Cipla
    Dr. Reddy's Laboratories
    Glenmark Pharmaceuticals
    Teva
    PuraCap Pharmaceutical
    TARO
    Lupin Pharmaceuticals
    Aurobindo Pharma
    Shanghai Bolinger Ingelheim Pharmaceutical
    Shanghai Zhaohui Pharmaceutical
    Sichuan Shenghe Pharmaceutical
    Ningxia Kangya Pharmaceutical
    Yangtze Pharmaceutical Group
    Kunshan Longdeng Ruidi Pharmaceutical
    Jiangsu Yabang Epson Pharmaceutical
    Jiangsu Feima Pharmaceutical Co. , Ltd
    Zhejiang Xianju Pharmaceutical
    Hainan All Star Pharmaceutical
1 Meloxicam Market Overview
    1.1 Product Overview and Scope of Meloxicam
    1.2 Meloxicam Segment by Ingredient
        1.2.1 Global Meloxicam Sales Growth Rate Comparison by Ingredient  (2021-2027)
        1.2.2 Combination Drugs
        1.2.3 Prescribed Drugs
    1.3 Meloxicam Segment by Application
        1.3.1 Meloxicam Sales Comparison by Application: (2021-2027)
        1.3.2 Rheumatoid Arthritis
        1.3.3 Osteoarthritis
        1.3.4 Soft Tissue Inflammation
        1.3.5 Traumatic Pain
        1.3.6 Post-Operative Pain
        1.3.7 Other
    1.4 Global Meloxicam Market Size Estimates and Forecasts
        1.4.1 Global Meloxicam Revenue 2016-2027
        1.4.2 Global Meloxicam Sales 2016-2027
        1.4.3 Meloxicam Market Size by Region: 2016 Versus 2021 Versus 2027

2 Meloxicam Market Competition by Manufacturers
    2.1 Global Meloxicam Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Meloxicam Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Meloxicam Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Meloxicam Manufacturing Sites, Area Served, Product Type
    2.5 Meloxicam Market Competitive Situation and Trends
        2.5.1 Meloxicam Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Meloxicam Players Market Share by Revenue
        2.5.3 Global Meloxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Meloxicam Retrospective Market Scenario by Region
    3.1 Global Meloxicam Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Meloxicam Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Meloxicam Market Facts & Figures by Country
        3.3.1 North America Meloxicam Sales by Country
        3.3.2 North America Meloxicam Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Meloxicam Market Facts & Figures by Country
        3.4.1 Europe Meloxicam Sales by Country
        3.4.2 Europe Meloxicam Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Meloxicam Market Facts & Figures by Region
        3.5.1 Asia Pacific Meloxicam Sales by Region
        3.5.2 Asia Pacific Meloxicam Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Meloxicam Market Facts & Figures by Country
        3.6.1 Latin America Meloxicam Sales by Country
        3.6.2 Latin America Meloxicam Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Meloxicam Market Facts & Figures by Country
        3.7.1 Middle East and Africa Meloxicam Sales by Country
        3.7.2 Middle East and Africa Meloxicam Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Meloxicam Historic Market Analysis by Type
    4.1 Global Meloxicam Sales Market Share by Type (2016-2021)
    4.2 Global Meloxicam Revenue Market Share by Type (2016-2021)
    4.3 Global Meloxicam Price by Type (2016-2021)

5 Global Meloxicam Historic Market Analysis by Application
    5.1 Global Meloxicam Sales Market Share by Application (2016-2021)
    5.2 Global Meloxicam Revenue Market Share by Application (2016-2021)
    5.3 Global Meloxicam Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Boehringer Ingelheim
        6.1.1 Boehringer Ingelheim Corporation Information
        6.1.2 Boehringer Ingelheim Description and Business Overview
        6.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Boehringer Ingelheim Product Portfolio
        6.1.5 Boehringer Ingelheim Recent Developments/Updates
    6.2 Baudax
        6.2.1 Baudax Corporation Information
        6.2.2 Baudax Description and Business Overview
        6.2.3 Baudax Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Baudax Product Portfolio
        6.2.5 Baudax Recent Developments/Updates
    6.3 Perrigo
        6.3.1 Perrigo Corporation Information
        6.3.2 Perrigo Description and Business Overview
        6.3.3 Perrigo Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Perrigo Product Portfolio
        6.3.5 Perrigo Recent Developments/Updates
    6.4 Recro Pharma
        6.4.1 Recro Pharma Corporation Information
        6.4.2 Recro Pharma Description and Business Overview
        6.4.3 Recro Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Recro Pharma Product Portfolio
        6.4.5 Recro Pharma Recent Developments/Updates
    6.5 Iroko Pharma
        6.5.1 Iroko Pharma Corporation Information
        6.5.2 Iroko Pharma Description and Business Overview
        6.5.3 Iroko Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Iroko Pharma Product Portfolio
        6.5.5 Iroko Pharma Recent Developments/Updates
    6.6 Zyla Life Sciences
        6.6.1 Zyla Life Sciences Corporation Information
        6.6.2 Zyla Life Sciences Description and Business Overview
        6.6.3 Zyla Life Sciences Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Zyla Life Sciences Product Portfolio
        6.6.5 Zyla Life Sciences Recent Developments/Updates
    6.7 Axsome Therapeutics
        6.6.1 Axsome Therapeutics Corporation Information
        6.6.2 Axsome Therapeutics Description and Business Overview
        6.6.3 Axsome Therapeutics Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Axsome Therapeutics Product Portfolio
        6.7.5 Axsome Therapeutics Recent Developments/Updates
    6.8 Orbis Biosciences
        6.8.1 Orbis Biosciences Corporation Information
        6.8.2 Orbis Biosciences Description and Business Overview
        6.8.3 Orbis Biosciences Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Orbis Biosciences Product Portfolio
        6.8.5 Orbis Biosciences Recent Developments/Updates
    6.9 Cellix Bio
        6.9.1 Cellix Bio Corporation Information
        6.9.2 Cellix Bio Description and Business Overview
        6.9.3 Cellix Bio Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Cellix Bio Product Portfolio
        6.9.5 Cellix Bio Recent Developments/Updates
    6.10 Ligand Pharma
        6.10.1 Ligand Pharma Corporation Information
        6.10.2 Ligand Pharma Description and Business Overview
        6.10.3 Ligand Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Ligand Pharma Product Portfolio
        6.10.5 Ligand Pharma Recent Developments/Updates
    6.11 SEDOR Pharma
        6.11.1 SEDOR Pharma Corporation Information
        6.11.2 SEDOR Pharma Meloxicam Description and Business Overview
        6.11.3 SEDOR Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 SEDOR Pharma Product Portfolio
        6.11.5 SEDOR Pharma Recent Developments/Updates
    6.12 Heron Therapeutics
        6.12.1 Heron Therapeutics Corporation Information
        6.12.2 Heron Therapeutics Meloxicam Description and Business Overview
        6.12.3 Heron Therapeutics Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Heron Therapeutics Product Portfolio
        6.12.5 Heron Therapeutics Recent Developments/Updates
    6.13 Pacira BioSciences
        6.13.1 Pacira BioSciences Corporation Information
        6.13.2 Pacira BioSciences Meloxicam Description and Business Overview
        6.13.3 Pacira BioSciences Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Pacira BioSciences Product Portfolio
        6.13.5 Pacira BioSciences Recent Developments/Updates
    6.14 Sanofi
        6.14.1 Sanofi Corporation Information
        6.14.2 Sanofi Meloxicam Description and Business Overview
        6.14.3 Sanofi Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Sanofi Product Portfolio
        6.14.5 Sanofi Recent Developments/Updates
    6.15 Eurofarma Laboratorio
        6.15.1 Eurofarma Laboratorio Corporation Information
        6.15.2 Eurofarma Laboratorio Meloxicam Description and Business Overview
        6.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Eurofarma Laboratorio Product Portfolio
        6.15.5 Eurofarma Laboratorio Recent Developments/Updates
    6.16 TerSera Therapeutics
        6.16.1 TerSera Therapeutics Corporation Information
        6.16.2 TerSera Therapeutics Meloxicam Description and Business Overview
        6.16.3 TerSera Therapeutics Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 TerSera Therapeutics Product Portfolio
        6.16.5 TerSera Therapeutics Recent Developments/Updates
    6.17 Apotex
        6.17.1 Apotex Corporation Information
        6.17.2 Apotex Meloxicam Description and Business Overview
        6.17.3 Apotex Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Apotex Product Portfolio
        6.17.5 Apotex Recent Developments/Updates
    6.18 Yung Shin Pharmaceutical
        6.18.1 Yung Shin Pharmaceutical Corporation Information
        6.18.2 Yung Shin Pharmaceutical Meloxicam Description and Business Overview
        6.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 Yung Shin Pharmaceutical Product Portfolio
        6.18.5 Yung Shin Pharmaceutical Recent Developments/Updates
    6.19 Breckenridge Pharmaceutical
        6.19.1 Breckenridge Pharmaceutical Corporation Information
        6.19.2 Breckenridge Pharmaceutical Meloxicam Description and Business Overview
        6.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Breckenridge Pharmaceutical Product Portfolio
        6.19.5 Breckenridge Pharmaceutical Recent Developments/Updates
    6.20 Zydus Pharmaceuticals
        6.20.1 Zydus Pharmaceuticals Corporation Information
        6.20.2 Zydus Pharmaceuticals Meloxicam Description and Business Overview
        6.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Zydus Pharmaceuticals Product Portfolio
        6.20.5 Zydus Pharmaceuticals Recent Developments/Updates
    6.21 Unichem Pharmaceuticals
        6.21.1 Unichem Pharmaceuticals Corporation Information
        6.21.2 Unichem Pharmaceuticals Meloxicam Description and Business Overview
        6.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Unichem Pharmaceuticals Product Portfolio
        6.21.5 Unichem Pharmaceuticals Recent Developments/Updates
    6.22 Strides Pharma
        6.22.1 Strides Pharma Corporation Information
        6.22.2 Strides Pharma Meloxicam Description and Business Overview
        6.22.3 Strides Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Strides Pharma Product Portfolio
        6.22.5 Strides Pharma Recent Developments/Updates
    6.23 Cipla
        6.23.1 Cipla Corporation Information
        6.23.2 Cipla Meloxicam Description and Business Overview
        6.23.3 Cipla Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Cipla Product Portfolio
        6.23.5 Cipla Recent Developments/Updates
    6.24 Dr. Reddy's Laboratories
        6.24.1 Dr. Reddy's Laboratories Corporation Information
        6.24.2 Dr. Reddy's Laboratories Meloxicam Description and Business Overview
        6.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Dr. Reddy's Laboratories Product Portfolio
        6.24.5 Dr. Reddy's Laboratories Recent Developments/Updates
    6.25 Glenmark Pharmaceuticals
        6.25.1 Glenmark Pharmaceuticals Corporation Information
        6.25.2 Glenmark Pharmaceuticals Meloxicam Description and Business Overview
        6.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 Glenmark Pharmaceuticals Product Portfolio
        6.25.5 Glenmark Pharmaceuticals Recent Developments/Updates
    6.26 Teva
        6.26.1 Teva Corporation Information
        6.26.2 Teva Meloxicam Description and Business Overview
        6.26.3 Teva Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Teva Product Portfolio
        6.26.5 Teva Recent Developments/Updates
    6.27 PuraCap Pharmaceutical
        6.27.1 PuraCap Pharmaceutical Corporation Information
        6.27.2 PuraCap Pharmaceutical Meloxicam Description and Business Overview
        6.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.27.4 PuraCap Pharmaceutical Product Portfolio
        6.27.5 PuraCap Pharmaceutical Recent Developments/Updates
    6.28 TARO
        6.28.1 TARO Corporation Information
        6.28.2 TARO Meloxicam Description and Business Overview
        6.28.3 TARO Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.28.4 TARO Product Portfolio
        6.28.5 TARO Recent Developments/Updates
    6.29 Lupin Pharmaceuticals
        6.29.1 Lupin Pharmaceuticals Corporation Information
        6.29.2 Lupin Pharmaceuticals Meloxicam Description and Business Overview
        6.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.29.4 Lupin Pharmaceuticals Product Portfolio
        6.29.5 Lupin Pharmaceuticals Recent Developments/Updates
    6.30 Aurobindo Pharma
        6.30.1 Aurobindo Pharma Corporation Information
        6.30.2 Aurobindo Pharma Meloxicam Description and Business Overview
        6.30.3 Aurobindo Pharma Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.30.4 Aurobindo Pharma Product Portfolio
        6.30.5 Aurobindo Pharma Recent Developments/Updates
    6.31 Shanghai Bolinger Ingelheim Pharmaceutical
        6.31.1 Shanghai Bolinger Ingelheim Pharmaceutical Corporation Information
        6.31.2 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Description and Business Overview
        6.31.3 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.31.4 Shanghai Bolinger Ingelheim Pharmaceutical Product Portfolio
        6.31.5 Shanghai Bolinger Ingelheim Pharmaceutical Recent Developments/Updates
    6.32 Shanghai Zhaohui Pharmaceutical
        6.32.1 Shanghai Zhaohui Pharmaceutical Corporation Information
        6.32.2 Shanghai Zhaohui Pharmaceutical Meloxicam Description and Business Overview
        6.32.3 Shanghai Zhaohui Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.32.4 Shanghai Zhaohui Pharmaceutical Product Portfolio
        6.32.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
    6.33 Sichuan Shenghe Pharmaceutical
        6.33.1 Sichuan Shenghe Pharmaceutical Corporation Information
        6.33.2 Sichuan Shenghe Pharmaceutical Meloxicam Description and Business Overview
        6.33.3 Sichuan Shenghe Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.33.4 Sichuan Shenghe Pharmaceutical Product Portfolio
        6.33.5 Sichuan Shenghe Pharmaceutical Recent Developments/Updates
    6.34 Ningxia Kangya Pharmaceutical
        6.34.1 Ningxia Kangya Pharmaceutical Corporation Information
        6.34.2 Ningxia Kangya Pharmaceutical Meloxicam Description and Business Overview
        6.34.3 Ningxia Kangya Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.34.4 Ningxia Kangya Pharmaceutical Product Portfolio
        6.34.5 Ningxia Kangya Pharmaceutical Recent Developments/Updates
    6.35 Yangtze Pharmaceutical Group
        6.35.1 Yangtze Pharmaceutical Group Corporation Information
        6.35.2 Yangtze Pharmaceutical Group Meloxicam Description and Business Overview
        6.35.3 Yangtze Pharmaceutical Group Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.35.4 Yangtze Pharmaceutical Group Product Portfolio
        6.35.5 Yangtze Pharmaceutical Group Recent Developments/Updates
    6.36 Kunshan Longdeng Ruidi Pharmaceutical
        6.36.1 Kunshan Longdeng Ruidi Pharmaceutical Corporation Information
        6.36.2 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Description and Business Overview
        6.36.3 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.36.4 Kunshan Longdeng Ruidi Pharmaceutical Product Portfolio
        6.36.5 Kunshan Longdeng Ruidi Pharmaceutical Recent Developments/Updates
    6.37 Jiangsu Yabang Epson Pharmaceutical
        6.37.1 Jiangsu Yabang Epson Pharmaceutical Corporation Information
        6.37.2 Jiangsu Yabang Epson Pharmaceutical Meloxicam Description and Business Overview
        6.37.3 Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.37.4 Jiangsu Yabang Epson Pharmaceutical Product Portfolio
        6.37.5 Jiangsu Yabang Epson Pharmaceutical Recent Developments/Updates
    6.38 Jiangsu Feima Pharmaceutical Co. , Ltd
        6.38.1 Jiangsu Feima Pharmaceutical Co. , Ltd Corporation Information
        6.38.2 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Description and Business Overview
        6.38.3 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.38.4 Jiangsu Feima Pharmaceutical Co. , Ltd Product Portfolio
        6.38.5 Jiangsu Feima Pharmaceutical Co. , Ltd Recent Developments/Updates
    6.39 Zhejiang Xianju Pharmaceutical
        6.39.1 Zhejiang Xianju Pharmaceutical Corporation Information
        6.39.2 Zhejiang Xianju Pharmaceutical Meloxicam Description and Business Overview
        6.39.3 Zhejiang Xianju Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.39.4 Zhejiang Xianju Pharmaceutical Product Portfolio
        6.39.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
    6.40 Hainan All Star Pharmaceutical
        6.40.1 Hainan All Star Pharmaceutical Corporation Information
        6.40.2 Hainan All Star Pharmaceutical Meloxicam Description and Business Overview
        6.40.3 Hainan All Star Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2016-2021)
        6.40.4 Hainan All Star Pharmaceutical Product Portfolio
        6.40.5 Hainan All Star Pharmaceutical Recent Developments/Updates
    6.41 Hainan Aomeihua Pharmaceutical
    6.42 Hunan Mingrui Pharmaceutical
    6.43 Suzhou Sinochem Pharmaceutical
    6.44 Qilu Pharmaceutical
    6.45 Sichuan Luye Pharmaceutical
    6.46 Shandong Xinhua Pharmaceutical
    6.47 Guangdong Renkang Pharmaceutical
    6.48 Hainan Selike Pharmaceutical

7 Meloxicam Manufacturing Cost Analysis
    7.1 Meloxicam Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Meloxicam
    7.4 Meloxicam Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Meloxicam Distributors List
    8.3 Meloxicam Customers

9 Meloxicam Market Dynamics
    9.1 Meloxicam Industry Trends
    9.2 Meloxicam Growth Drivers
    9.3 Meloxicam Market Challenges
    9.4 Meloxicam Market Restraints

10 Global Market Forecast
    10.1 Meloxicam Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Meloxicam by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Meloxicam by Type (2022-2027)
    10.2 Meloxicam Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Meloxicam by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Meloxicam by Application (2022-2027)
    10.3 Meloxicam Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Meloxicam by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Meloxicam by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Meloxicam Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Meloxicam Sales (KG) Comparison by Application (2021-2027) Table 3. Global Meloxicam Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Meloxicam Covered in This Study Table 5. Global Meloxicam Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Meloxicam Sales Share by Manufacturers (2016-2021) Table 7. Global Meloxicam Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Meloxicam Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Meloxicam Average Price (US$/G) of Key Manufacturers (2016-2021) Table 10. Manufacturers Meloxicam Manufacturing Sites and Area Served Table 11. Manufacturers Meloxicam Product Type Table 12. Global Meloxicam Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Meloxicam by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meloxicam as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Meloxicam Sales by Region (2016-2021) & (KG) Table 16. Global Meloxicam Sales Market Share by Region (2016-2021) Table 17. Global Meloxicam Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Meloxicam Sales by Country (2016-2021) & (KG) Table 19. North America Meloxicam Sales Market Share by Country (2016-2021) Table 20. North America Meloxicam Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Meloxicam Revenue Market Share by Country (2016-2021) Table 22. Europe Meloxicam Sales by Country (2016-2021) & (KG) Table 23. Europe Meloxicam Sales Market Share by Country (2016-2021) Table 24. Europe Meloxicam Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Meloxicam Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Meloxicam Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Meloxicam Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Meloxicam Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Meloxicam Revenue Market Share by Region (2016-2021) Table 30. Latin America Meloxicam Sales by Country (2016-2021) & (KG) Table 31. Latin America Meloxicam Sales Market Share by Country (2016-2021) Table 32. Latin America Meloxicam Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Meloxicam Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Meloxicam Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Meloxicam Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Meloxicam Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Meloxicam Revenue Market Share by Country (2016-2021) Table 38. Global Meloxicam Sales (KG) by Type (2016-2021) Table 39. Global Meloxicam Sales Market Share by Type (2016-2021) Table 40. Global Meloxicam Revenue (Million US$) by Type (2016-2021) Table 41. Global Meloxicam Revenue Share by Type (2016-2021) Table 42. Global Meloxicam Price (US$/G) by Type (2016-2021) Table 43. Global Meloxicam Sales (KG) by Application (2016-2021) Table 44. Global Meloxicam Sales Market Share by Application (2016-2021) Table 45. Global Meloxicam Revenue (Million US$) by Application (2016-2021) Table 46. Global Meloxicam Revenue Share by Application (2016-2021) Table 47. Global Meloxicam Price (US$/G) by Application (2016-2021) Table 48. Boehringer Ingelheim Corporation Information Table 49. Boehringer Ingelheim Description and Business Overview Table 50. Boehringer Ingelheim Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 51. Boehringer Ingelheim Meloxicam Product Table 52. Boehringer Ingelheim Recent Developments/Updates Table 53. Baudax Corporation Information Table 54. Baudax Description and Business Overview Table 55. Baudax Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 56. Baudax Meloxicam Product Table 57. Baudax Recent Developments/Updates Table 58. Perrigo Corporation Information Table 59. Perrigo Description and Business Overview Table 60. Perrigo Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 61. Perrigo Meloxicam Product Table 62. Perrigo Recent Developments/Updates Table 63. Recro Pharma Corporation Information Table 64. Recro Pharma Description and Business Overview Table 65. Recro Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 66. Recro Pharma Meloxicam Product Table 67. Recro Pharma Recent Developments/Updates Table 68. Iroko Pharma Corporation Information Table 69. Iroko Pharma Description and Business Overview Table 70. Iroko Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 71. Iroko Pharma Meloxicam Product Table 72. Iroko Pharma Recent Developments/Updates Table 73. Zyla Life Sciences Corporation Information Table 74. Zyla Life Sciences Description and Business Overview Table 75. Zyla Life Sciences Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 76. Zyla Life Sciences Meloxicam Product Table 77. Zyla Life Sciences Recent Developments/Updates Table 78. Axsome Therapeutics Corporation Information Table 79. Axsome Therapeutics Description and Business Overview Table 80. Axsome Therapeutics Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 81. Axsome Therapeutics Meloxicam Product Table 82. Axsome Therapeutics Recent Developments/Updates Table 83. Orbis Biosciences Corporation Information Table 84. Orbis Biosciences Description and Business Overview Table 85. Orbis Biosciences Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 86. Orbis Biosciences Meloxicam Product Table 87. Orbis Biosciences Recent Developments/Updates Table 88. Cellix Bio Corporation Information Table 89. Cellix Bio Description and Business Overview Table 90. Cellix Bio Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 91. Cellix Bio Meloxicam Product Table 92. Cellix Bio Recent Developments/Updates Table 93. Ligand Pharma Corporation Information Table 94. Ligand Pharma Description and Business Overview Table 95. Ligand Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 96. Ligand Pharma Meloxicam Product Table 97. Ligand Pharma Recent Developments/Updates Table 98. SEDOR Pharma Corporation Information Table 99. SEDOR Pharma Description and Business Overview Table 100. SEDOR Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 101. SEDOR Pharma Meloxicam Product Table 102. SEDOR Pharma Recent Developments/Updates Table 103. Heron Therapeutics Corporation Information Table 104. Heron Therapeutics Description and Business Overview Table 105. Heron Therapeutics Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 106. Heron Therapeutics Meloxicam Product Table 107. Heron Therapeutics Recent Developments/Updates Table 108. Pacira BioSciences Corporation Information Table 109. Pacira BioSciences Description and Business Overview Table 110. Pacira BioSciences Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 111. Pacira BioSciences Meloxicam Product Table 112. Pacira BioSciences Recent Developments/Updates Table 113. Sanofi Corporation Information Table 114. Sanofi Description and Business Overview Table 115. Sanofi Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 116. Sanofi Meloxicam Product Table 117. Sanofi Recent Developments/Updates Table 118. Eurofarma Laboratorio Corporation Information Table 119. Eurofarma Laboratorio Description and Business Overview Table 120. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 121. Eurofarma Laboratorio Meloxicam Product Table 122. Eurofarma Laboratorio Recent Developments/Updates Table 123. TerSera Therapeutics Corporation Information Table 124. TerSera Therapeutics Description and Business Overview Table 125. TerSera Therapeutics Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 126. TerSera Therapeutics Meloxicam Product Table 127. TerSera Therapeutics Recent Developments/Updates Table 128. Apotex Corporation Information Table 129. Apotex Description and Business Overview Table 130. Apotex Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 131. Apotex Meloxicam Product Table 132. Apotex Recent Developments/Updates Table 133. Yung Shin Pharmaceutical Corporation Information Table 134. Yung Shin Pharmaceutical Description and Business Overview Table 135. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 136. Yung Shin Pharmaceutical Meloxicam Product Table 137. Yung Shin Pharmaceutical Recent Developments/Updates Table 138. Breckenridge Pharmaceutical Corporation Information Table 139. Breckenridge Pharmaceutical Description and Business Overview Table 140. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 141. Breckenridge Pharmaceutical Meloxicam Product Table 142. Breckenridge Pharmaceutical Recent Developments/Updates Table 143. Zydus Pharmaceuticals Corporation Information Table 144. Zydus Pharmaceuticals Description and Business Overview Table 145. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 146. Zydus Pharmaceuticals Meloxicam Product Table 147. Zydus Pharmaceuticals Recent Developments/Updates Table 148. Unichem Pharmaceuticals Corporation Information Table 149. Unichem Pharmaceuticals Description and Business Overview Table 150. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 151. Unichem Pharmaceuticals Meloxicam Product Table 152. Unichem Pharmaceuticals Recent Developments/Updates Table 153. Strides Pharma Corporation Information Table 154. Strides Pharma Description and Business Overview Table 155. Strides Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 156. Strides Pharma Meloxicam Product Table 157. Strides Pharma Recent Developments/Updates Table 158. Cipla Corporation Information Table 159. Cipla Description and Business Overview Table 160. Cipla Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 161. Cipla Meloxicam Product Table 162. Cipla Recent Developments/Updates Table 163. Dr. Reddy's Laboratories Corporation Information Table 164. Dr. Reddy's Laboratories Description and Business Overview Table 165. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 166. Dr. Reddy's Laboratories Meloxicam Product Table 167. Dr. Reddy's Laboratories Recent Developments/Updates Table 168. Glenmark Pharmaceuticals Corporation Information Table 169. Glenmark Pharmaceuticals Description and Business Overview Table 170. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 171. Glenmark Pharmaceuticals Meloxicam Product Table 172. Glenmark Pharmaceuticals Recent Developments/Updates Table 173. Teva Corporation Information Table 174. Teva Description and Business Overview Table 175. Teva Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 176. Teva Meloxicam Product Table 177. Teva Recent Developments/Updates Table 178. PuraCap Pharmaceutical Corporation Information Table 179. PuraCap Pharmaceutical Description and Business Overview Table 180. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 181. PuraCap Pharmaceutical Meloxicam Product Table 182. PuraCap Pharmaceutical Recent Developments/Updates Table 183. TARO Corporation Information Table 184. TARO Description and Business Overview Table 185. TARO Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 186. TARO Meloxicam Product Table 187. TARO Recent Developments/Updates Table 188. Lupin Pharmaceuticals Corporation Information Table 189. Lupin Pharmaceuticals Description and Business Overview Table 190. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 191. Lupin Pharmaceuticals Meloxicam Product Table 192. Lupin Pharmaceuticals Recent Developments/Updates Table 193. Aurobindo Pharma Corporation Information Table 194. Aurobindo Pharma Description and Business Overview Table 195. Aurobindo Pharma Meloxicam Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 196. Aurobindo Pharma Meloxicam Product Table 197. Aurobindo Pharma Recent Developments/Updates Table 198. Production Base and Market Concentration Rate of Raw Material Table 199. Key Suppliers of Raw Materials Table 200. Meloxicam Distributors List Table 201. Meloxicam Customers List Table 202. Meloxicam Market Trends Table 203. Meloxicam Growth Drivers Table 204. Meloxicam Market Restraints Table 205. Global Meloxicam Sales Forecast by Type (2022-2027) & (KG) Table 206. Global Meloxicam Sales Market Share Forecast by Type (2022-2027) Table 207. Global Meloxicam Revenue Forecast by Type (2022-2027) & (US$ Million) Table 208. Global Meloxicam Revenue Market Share Forecast by Type (2022-2027) Table 209. Global Meloxicam Sales Forecast by Application (2022-2027) & (KG) Table 210. Global Meloxicam Sales Market Share Forecast by Application (2022-2027) Table 211. Global Meloxicam Revenue Forecast by Application (2022-2027) & (US$ Million) Table 212. Global Meloxicam Revenue Market Share Forecast by Application (2022-2027) Table 213. Global Meloxicam Sales Forecast by Region (2022-2027) & (KG) Table 214. Global Meloxicam Sales Market Share Forecast by Region (2022-2027) Table 215. Global Meloxicam Revenue Forecast by Region (2022-2027) & (US$ Million) Table 216. Global Meloxicam Revenue Market Share Forecast by Region (2022-2027) Table 217. Research Programs/Design for This Report Table 218. Key Data Information from Secondary Sources Table 219. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Meloxicam Figure 2. Global Meloxicam Market Share by Type in 2020 & 2027 Figure 3. Combination Drugs Product Picture Figure 4. Prescribed Drugs Product Picture Figure 5. Global Meloxicam Market Share by Application in 2020 & 2027 Figure 6. Rheumatoid Arthritis Figure 7. Osteoarthritis Figure 8. Soft Tissue Inflammation Figure 9. Traumatic Pain Figure 10. Post-Operative Pain Figure 11. Other Figure 12. Global Meloxicam Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Meloxicam Market Size 2016-2027 (US$ Million) Figure 14. Global Meloxicam Sales 2016-2027 (KG) Figure 15. Global Meloxicam Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Meloxicam Sales Share by Manufacturers in 2020 Figure 17. Global Meloxicam Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Meloxicam Players: Market Share by Revenue in 2020 Figure 19. Meloxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Meloxicam Sales Market Share by Region (2016-2021) Figure 21. Global Meloxicam Sales Market Share by Region in 2020 Figure 22. Global Meloxicam Revenue Market Share by Region (2016-2021) Figure 23. Global Meloxicam Revenue Market Share by Region in 2020 Figure 24. U.S. Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. UAE Meloxicam Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Meloxicam by Type (2016-2021) Figure 49. Sales Market Share of Meloxicam by Application (2016-2021) Figure 50. Sales Market Share of Meloxicam by Application in 2020 Figure 51. Revenue Share of Meloxicam by Application (2016-2021) Figure 52. Revenue Share of Meloxicam by Application in 2020 Figure 53. Manufacturing Cost Structure of Meloxicam Figure 54. Manufacturing Process Analysis of Meloxicam Figure 55. Meloxicam Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us